66L-17831-79038

3 vaccinations 10 coded responses 28 check-ins 9 free-text entries 2 call cases

Sex: Female
Age at first dose: 26-30
ZIP prefix: 986 / WA
Registered: 2021-07-14

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2088899 (opens in a new window)	high	9 / 11	—	2 of 11 VAERS symptoms	same dose (3)	WA matches	2022-01-18 / 2022-01-18 / 2022-02-04 received the same day as the last call	case 144569

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-06-15
Dose 1 — Pfizer-BioNTech
2021-07-14
Registered in v-safe
2021-07-14
Dose 2 — Pfizer-BioNTech
2021-07-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-07-16
Survey response — days 1–6 daily, dose 2
MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Slight increase in asthma symptoms

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-07-18
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-07-19
Survey response — days 1–6 daily, dose 2
MedDRA: Asthenia, Dizziness, Peripheral coldness, Temperature regulation disorder — Feeling: Poor · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Trouble regulating body temp and keeping hands/feet warm, dizzy and weak.

MedDRA releases: 2024-11 · check-in free text available
2021-07-20
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site mass — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: A lump in my arm at the injection site

MedDRA releases: 2024-11 · check-in free text available
2021-07-21
Health check-in — day 7, dose 2
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-07-28
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-08-04
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-08-11
Survey response — day 28, dose 2
MedDRA: Urticaria — Feeling: Good

Free text: Broke out in hives in different areas of the body, unsure what caused them.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-18
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-08-25
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-10-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-01-12
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2022-01-18
Dose 3 — Pfizer-BioNTech
2022-01-19
Survey response — days 1–6 daily, dose 3
MedDRA: Injection site warmth — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: The injection site is warm to the touch

MedDRA releases: 2024-11 · check-in free text available
2022-01-21
Survey response — days 1–6 daily, dose 3
MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness, Diarrhea

Free text: Mild Bruising at injection site

MedDRA releases: 2024-11 · check-in free text available
2022-01-22
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-01-23
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-01-24
Survey response — days 1–6 daily, dose 3
MedDRA: Asthma, Cough, Dyspnoea, Pre-existing disease, Rhinorrhoea — Feeling: Fair · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work or attend school

Free text: Coughing, severe runny nose, difficulty breathing, increased use of asthma emergency inhaler.

MedDRA releases: 2024-11 · check-in free text available
2022-01-25
Survey response — day 7, dose 3
MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches · Be unable to work or attend school

Free text: Runny nose, coughing, sneezing.

MedDRA releases: 2024-11 · check-in free text available
2022-02-01
Survey response — day 14, dose 3
MedDRA: Exposure to SARS-CoV-2, Pneumonia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Pneumonia, and then covid exposure

MedDRA releases: 2024-11 · check-in free text available
2022-02-01
Report sent to call center — day 14, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-04
Call successful
Completed over the phone
2022-02-08
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2022-02-15
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-02-22
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-03-01
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2022-04-19
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-07-19
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2023-01-18
Survey response — 12 months, dose 3
MedDRA: COVID-19, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-01-18
Report sent to call center — 12 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-01-19
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-06-15	Pfizer-BioNTech	No
2	2021-07-14	Pfizer-BioNTech	No
3	2022-01-18	Pfizer-BioNTech	No

Call center

2 call center cases

1 successful · 1 unsuccessful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 9 — days 1–6 daily, dose 2

2021-07-16

Systemic reaction (other): Slight increase in asthma symptoms

2021-07-19

Systemic reaction (other): Trouble regulating body temp and keeping hands/feet warm, dizzy and weak.

2021-07-20

Systemic reaction (other): A lump in my arm at the injection site

Release 9 — day 28, dose 2

2021-08-11

Symptoms: Broke out in hives in different areas of the body, unsure what caused them.

Release 10 — days 1–6 daily, dose 3

2022-01-19

Systemic reaction (other): The injection site is warm to the touch

Release 11 — days 1–6 daily, dose 3

2022-01-21

Systemic reaction (other): Mild Bruising at injection site

2022-01-24

Systemic reaction (other): Coughing, severe runny nose, difficulty breathing, increased use of asthma emergency inhaler.

Release 11 — day 7, dose 3

2022-01-25

Systemic reaction (other): Runny nose, coughing, sneezing.

Release 11 — day 14, dose 3

2022-02-01

Symptoms: Pneumonia, and then covid exposure

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Exposure to SARS-CoV-2	·	·	✓
SD	Pneumonia	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Urticaria	✓	·	✓
SRO	Asthenia	·	·	✓
SRO	Asthma	✓	·	✓
SRO	Cough	·	·	✓
SRO	Dizziness	·	·	✓
SRO	Dyspnoea	·	·	✓
SRO	Injection site bruising	·	·	✓
SRO	Injection site mass	·	·	✓
SRO	Injection site warmth	·	·	✓
SRO	Peripheral coldness	·	·	✓
SRO	Pre-existing disease	✓	·	✓
SRO	Rhinorrhoea	·	·	✓
SRO	Sneezing	·	·	✓
SRO	Temperature regulation disorder	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release